최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국콘텐츠학회논문지 = The Journal of the Korea Contents Association, v.13 no.12, 2013년, pp.880 - 892
김인수 (동신대학교 방사선학과) , 정명호 (전남대학교병원 심혈관센터) , 한재복 (동신대학교 방사선학과) , 장영일 (광양보건대학교 방사선과) , 장성주 (동신대학교 방사선학과)
Stent thrombosis after successful drug-eluting stent(DES) implantation has been reported in around 1% of patients in clinical trials. However, the increased risk of ST associated with DES remains a matter of concern. From 1 June 2003 to 30 June 2013, we investigated clinical characteristics, in-hosp...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
D. R. jr. Holmes, M. B. Leon, J. W. Moses, J. J. Popma, D. Cutlip, and P. J. Fitzgerald, "Analysis of 1-year clinical out comes in the SIRIUS trial: a randomized trial of a sirolimus -eluting stent versus a standard stent in patients at high risk for coronary restenosis," Circulation, Vol.109, pp.634-640, 2004.
A. M. Salam, J. Suwaidi, and D. R. jr. Holmes "Drug-eluting coronary stents," Curr Probl Cardiol, Vol.31, pp.8-119, 2006.
M. B. Leon and A. Bakhai, "Drug-eluting stents glycoprotein IIb/IIIa inhibitors combination therapy for the future," J. Am Heart, Vol.146, pp.S13-7, 2003.
G. S. Mintz, A. Tinana, M. K. Hong, C. W. Lee, J. J. Kim, and N. E. Fearnot, "Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxelcoated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)," Circulation, Vol.108, pp.1295-1298, 2013.
J. R. Nebeker, R. Virmani, C. L. Bennett, J. M. Hoffman, M. H. Samore, and J. Alvarez, "Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project," J Am Coll Cardiol, Vol.47, pp.175-181, 2006.
R. Virmani, A. Farb, G. Guagliumi, and F. D. Kolodgie, "Drug-eluting stents:caution and concerns for long-term outcome," Coron Artery Dis, Vol.15, pp.313-318, 2004.
P. W. Serruys, B. van Hout, H. Bonnier, V. Legrand, E. Garcia, and C. "Macaya, Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)," Lancet, Vol.352, pp.673-681, 1998.
B. L.van der Hoeven, S. S. Liem, and J. W. Jukema, "Sirolimus-eluting stents versus bare-metal stents in patients with ST -segment elevation myocardia infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study," J Am Coll Cardiol, Vol.51, pp.618-626, 2008.
N. Guo, A. Maehara, and G. S. Mintz, "Incidence, mechanisms, predictors and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction:an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial," Circulation, Vol.122, pp.1077-1084.
G. Nakazawa, A. V. Finn, and M. Joner, "Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients an autopsy study," Circulation, Vol.118, pp.1138-1145, 2008.
S. Cook, P. Wenaweser, M. Togni, M. Billinger, C. Morger, C. Seiler, R. Vogel, O. M. Hess, B. Meier, and S. Windecker, "Incomplete stent apposition and late stent thrombosis followingdrug-eluting stent implantation," Circulation, Vol.115, pp.2426-2434, 2007.
R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco, T. Motta, L. Mihalcsik, M. Tespili, O. Valsecchi, and F. D. Kolodgie, "Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent," Circulation, Vol.109, pp.701-705, 2004.
J. R. Nebeker, R. Virmani, C. L. Bennett, J. M. Hoffman, M. H. Samore, J. Alvarez, C. J. Davidson, J. M. McKoy, D. W. WRaisch, B. K. Whisenant, P. R. S. M. Yarnold, D. P. Belknap, J. E. West, Gage, R. E. G. F. Morse Gligoric, L. Davidson, and M. D. Feldman, "Hypersensitivity cases associated with drug-eluting coronary stents," J Am Coll Cardiol, Vol.47, pp.175-181, 2006.
M. J oner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani, "Pathology of drugeluting stents in humans," J Am Coll Cardiol, Vol.48, pp.193-202, 2006.
I. S. Kim, N. G. Choi, J. B. Han, S. J. Jang, and Y. I. Jang, "Clinical outcome of stent thrombosis in patients with acute myocardial infarction," J. of Contents Association, Vol.12, No.7, pp.273-283, 2012.
D. E. Cutlip, S. Windecker, and R. Mehran, "Clinical end points in coronary stent trials: a case for standardized definitions," Circulation, Vol.115, pp.2344-2351, 2007.
D. E. Cutlip, D. S. Baim, K. K. Ho, J. J. Popma, A. J. Lansky, D. J. Cohen, J. P. jr Carrozza, M. S. Chauhan, O. Rodriguez, and R. E. Kuntz, "Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials," Circulation, Vol.103, pp.1967-1971, 2001.
J. M. Brennan, J. P. Curtis, D. Dai, S. Fitzgerald, A. K. Khandelwal, J. A. Spertus, S. V. Rao, M. Singh, R. E. Shaw, K. K. Ho, R. J. Krone, W. S. Weintraub, W. D. Weaver, and E. D. Peterson, "National Cardiovascular Data Registry. Enhanced Mortality Risk Prediction With a Focus on High-Risk Percutaneous Coronary Intervention: Results From 1,208,137 Procedures in the NCDR(National Cardiovascular Data Registry)," JACC Cardiovasc Interv, Vol.6, No.8, pp.790-799, 2013.
J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Juni, G. Sianos, G. Hellige, R. T. van Domburg, O. M. Hess, E. Boersma, B. Meier, S. Windecker, and P. W. Serruys, "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study," Lancet, Vol.369, pp.667-678, 2007.
K. W. Park, S. J. Hwang, D. A. Kwon, B. H. Oh, Y. B. Park, I. H. Chae, H. C. Gwon, S. J. Park, K. B. Seung, T. Ahn, J. H. Yoon, Y. S. Jang, M. H. Jeong, S. J. Tahk, and H. S. Kim, "Korea Stent Thrombosis Investigators. Characteristics and predictors of drug-eluting stent thrombosis" results from the multicenter 'Korea Stent Thrombosis (KoST)' registry," Circ J, Vol.75, pp.1626-1632, 2011.
J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, and C. Morger, "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study," Lancet, Vol.369, pp.667-678, 2007.
G. W. Stone, J. W. Moses, S. G. Ellis, J. Schofer, K. D. Dawkins, and M. C. Morice, "Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents," N Engl J Med, Vol.356, pp.998-1008, 2007.
L. Mauri, W. H. Hsieh, J. M. Massaro, K. K. Ho, R. D'Agostino, and D. E. Cutlip, "Stent thrombosis in randomized clinical trials of drug-eluting stents," N Engl J Med, Vol.356, pp.1020-1029, 2007.
A. T. Ong, A. Hoye, J. Aoki, C. A. van Mieghem, G. A. Rodriguez Granillo, and K. Sonnenschein, "Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation," J Am Coll Cardiol, Vol.45, pp.947-953, 2005.
A. A. Bavry, D. J. Kumbhani, T. J. Helton, and D. L. Bhatt, "Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention," Am J Cardiol, Vol.95, pp.1469-1472, 2005.
A. A. Bavry, D. J. Kumbhani, T. J. Helton, and D. L. Bhatt, "What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?," J Am Coll Cardiol, Vol.245, pp.941-946, 2005.
A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli, and H. Kelbaek, "Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents," N Engl J Med, Vol.356, pp.1030-1039, 2007.
D. W. Park, S. W. Park, K. H. Park, B. K. Lee, Y. H. Kim, and C. W. Lee, "Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up," Am J Cardiol, Vol.98, pp.352-356, 2006.
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. M. Sangiorgi, and G. Stankovic, "Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents," JAMA, Vol.293, pp.2126-2130, 2005.
A. T. Ong, A. Hoye, J. Aoki, C. A. van G. A. Mieghem, Rodriguez Granillo, and K. Sonnenschein, "Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation," J Am Coll Cardiol, Vol.45, pp.947-953, 2005.
J. M. Lasala, D. A. Cox, D. Dobies, K. Baran, W. B. Bachinsky, and E. W. Rogers, "Drug-eluting stent thrombosis in routine clinical practice: Two-year outcomes and predictors from the TAXUS ARRIVE registries," Circ Cardiovasc Interv, Vol.2, pp.285-293, 2009.
F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave and L. Buellesfeld, "Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment," Circulation, Vol.116, pp.745-754, 2007.
Y. S. Ahn, J. H. Cho, D. H. Kim, Y. J. Hwang, H. M. Jung, and M. S. Choi, "A fatal case of simultaneous, very late thrombosis involving three drug-eluting stents in three coronary arteries," Korean Circ J, Vol.38, pp.564-569, 2008.
O. K. Siddiqi and D. P. Faxon, "Very late stent thrombosis: current concepts," Curr Opin Cardiol, Vol.27, pp.634-641, 2012.
K. Sudhir, J. B. Hermiller, J. M. Ferguson, and C. A. Simonton, "Risk Factors for Coronary Drug-Eluting Stent Thrombosis: Influence of Procedural, Patient, Lesion and Stent Related Factors and Dual Antiplatelet Therapy," ISRN Cardiol, Vol.748736, 2013(6).
G. G. Stefanini, B. Kalesan, P. W. Serruys, D. Heg, P. Buszman, A. Linke, T. Ischinger, V. Klauss, F. Eberli, W. Wijns, M. C. Morice, C. Di Mario, R. Corti, D. Antoni, H. Y. Sohn, P. Eerdmans, G. A. van Es, B. Meier, S. Windecker, and P. Juni, "Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial," Lancet, Vol.378, pp.1940-1948, 2011.
H. Kitabata, J. P. Loh, L. K. Pendyala, S. Badr, D. Dvir, I. M. Barbash, S. Minha, R. Torguson, F. Chen, L. F. Satler, W. O. Suddath, K. M. Kent, A. D. Pichard, and R. Waksman, "Safety and efficacy outcomes of overlapping second generation everolimus eluting stents versus first generation drug eluting stents," Am J Cardiol, Vol.112, No.8, pp.1093-1098, 2013(10).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.